BRCA1 and breast cancer: We examined the differences in the sensitivity of the HCC1937 human breast cancer cell line harbouring a BRCA1 mutation and with complete loss of BRCA1 function, compared with hormone-sensitive MCF-7 and hormone-insensitive MDA-MB231 cell lines, to chemotherapeutic agents that are commonly used in the treatment of breast cancer.